Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCLC | P48506 | 1/20 | 0.36 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.33 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.32 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.32 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 2/20 | 0.32 |
| ▸ | LAP3 | P28838 | 1/20 | 0.32 |
| ▸ | METAP1 | P53582 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16163303 | 0.88 | LPAR3 (0.53) | PLA2G2DFDPSLPAR3LPAR2 | |
| SCHEMBL19455883 | 0.84 | FDPS (0.39) | PLA2G2DFDPSLAP3METAP1LPAR3 | |
| SCHEMBL16163356 | 0.84 | GABBR2 (0.47) | PLA2G2DGABBR2GABRR1GABBR1FDPS | |
| SCHEMBL16208973 | 0.83 | PLA2G2D (0.34) | PLA2G2DGABBR2GABRR1GABBR1FDPS | |
| SCHEMBL16163284 | 0.82 | FDPS (0.44) | PLA2G2DGABBR2GABRR1GABBR1FDPS | |
| SCHEMBL16163412 | 0.82 | LPAR3 (0.45) | PLA2G2DGABBR2GABRR1GABBR1LPAR3 | |
| SCHEMBL16163129 | 0.81 | LPAR3 (0.48) | PLA2G2DFDPSLPAR3LPAR2 | |
| SCHEMBL16163200 | 0.74 | GABBR2 (0.35) | GCLCGABBR2GABBR1FDPSLAP3 | |
| SCHEMBL339643 | 0.73 | FOLH1 (0.35) | GCLCFDPSLAP3 | |
| SCHEMBL2513023 | 0.73 | TRPM8 (0.46) | GCLCGABBR2GABRR1GABBR1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2791152-B1 | MIXTURES OF DIPHOSPHINIC ACIDS AND DIALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2018-11-07 | — | — | EP | claimed |
| EP-2791149-B1 | MIXTURES OF DIPHOSPHINIC ACIDS AND ALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2017-06-14 | — | — | EP | claimed |
| US-20150005421-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-01-01 | — | — | US | claimed |
| US-20140329933-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2014-11-06 | — | — | US | claimed |
| US-20140309339-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-10-16 | — | — | US | claimed |
| US-20180030355-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2018-02-01 | — | — | US | disclosed |
| US-20170313942-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2017-11-02 | — | — | US | disclosed |
| EP-2791149-B1 | MIXTURES OF DIPHOSPHINIC ACIDS AND ALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2017-06-14 | — | — | EP | disclosed |
| US-20150005421-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-01-01 | — | — | US | disclosed |
| US-20140329933-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2014-11-06 | — | — | US | disclosed |
| US-20140309339-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030355-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | PHOSPHO1, ENPP2, INPPL1 | GCLC 3623/4885PLA2G2D 82/4885GABBR2 2790/4885 |
| US-20170313942-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | C3AR1, DCPS, ENPP2 | GCLC 3876/4885PLA2G2D 255/4885GABBR2 2368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.